Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis
Frontiers in Drug Safety and Regulation · 23.07.2026 · 6
DOI: 10.3389/fdsfr.2026.1864872 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Drug Safety and Regulation, online erschienen am 23.07.2026. Verfasst von Alaa Baqer Alali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Independent Practitioner, Al-Hasa, Saudi Arabia. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Topical retinoids are commonly prescribed for dermatological conditions during reproductive years; however, concerns regarding teratogenicity have persisted due to the established risks associated with oral retinoids. This systematic review and meta-analysis aimed to evaluate the association between first-trimester topical retinoid exposure and risks of major congenital malformations (MCM) and spontaneous abortion (SAB).
Methods
Following PRISMA 2020 guidelines, we searched PubMed, Scopus, Cochrane Library, Web of Science, and Google Scholar up to November 25, 2025. Studies comparing pregnancy outcomes in women exposed to topical retinoids versus unexposed controls were included. Random-effects meta-analysis, Bayesian hierarchical modeling with multiple prior specifications, and Robust Bayesian Model-Averaged (RoBMA) analysis were performed.
Results
Eight studies with total of 3,632,118 pregnancies were included. Topical retinoid exposure was not significantly associated with MCM risk (risk ratio [RR] 0.83, 95% CI 0.64–1.07, P-value = 0.14, I 2 = 0%) or SAB risk (RR 0.99, 95% CI 0.68–1.43, P-value = 0.94, I 2 = 0%). Bayesian analysis with three prior specifications yielded posterior estimates ranging from RR 0.86 to 0.89, all with credible intervals crossing unity. RoBMA demonstrated 74.1% posterior probability favoring the null hypothesis (BF 10 = 0.35). Leave-one-out sensitivity analysis identified Refsum et al., 2025 as influential for MCM (+29.6% change when omitted). E-value analysis indicated findings were not significant to unmeasured confounding.
Conclusion
Topical retinoid exposure during the first trimester was not associated with increased risks of MCM or SAB. These findings support the relative safety of topical retinoids in early pregnancy; however the results were driven mainly by a single large registry study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Independent Practitioner, Al-Hasa, Saudi Arabia.
- Consultant, Al-Hasa, Saudi Arabia.
Zitieren
APA
Alali, A. B., Alhammad, F. A., Almohammed Saleh, J. A., Alshaikh, S. B., Alshayeb, Z. K., Al Nujaidi, A. J., Albinsaleh, A. A., Almutawah, M. R., Alhodibi, M. H., & Albesher, M. A. (2026). Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis. Frontiers in Drug Safety and Regulation, 6. https://doi.org/10.3389/fdsfr.2026.1864872
Vancouver
Alali AB, Alhammad FA, Almohammed Saleh JA, Alshaikh SB, Alshayeb ZK, Al Nujaidi AJ, et al. Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis. Frontiers in Drug Safety and Regulation. 2026;6. doi:10.3389/fdsfr.2026.1864872
BibTeX
@article{Alali2026,
author = {Alali, Alaa Baqer and Alhammad, Fatimah Ahmed and Almohammed Saleh, Jumanah Ameer and Alshaikh, Salwa Baqer and Alshayeb, Zahraa Khaled and Al Nujaidi, Anfal Jaber and Albinsaleh, Ahmed Abdulmohsen and Almutawah, Mohammed Radhi and Alhodibi, Mostafa Habeeb and Albesher, Muslem Adel},
title = {Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis},
journal = {Frontiers in Drug Safety and Regulation},
year = {2026},
volume = {6},
doi = {10.3389/fdsfr.2026.1864872}
}
EUVIMED